Publications by authors named "S T Shulman"
Article Synopsis
- The study assessed the effectiveness of a modified regimen (mRAISE) using corticosteroids as an adjunctive therapy along with IVIG and aspirin for high-risk Kawasaki Disease (KD) patients in North America.
- A total of 221 patients were reviewed from 2010 to 2023, with 83 receiving the mRAISE treatment and 138 not.
- Results showed no significant differences in coronary artery outcomes between the two groups, but mRAISE patients were less likely to require multiple doses of IVIG compared to those who did not receive this regimen.
Background: Ocular manifestations (OMs) in patients with inflammatory bowel disease (IBD) are uncommon, particularly in children. We aimed to explore the prevalence and characteristics of IBD-associated OM in a large cohort study.
Methods: A cross-sectional study was performed using the Maccabi Healthcare Services (MHS) database.
Background: Kawasaki disease (KD) is an acute febrile illness of childhood that can lead to coronary artery aneurysms (CAAs) and myocardial infarction. Intravenous immunoglobulin reduces the prevalence of CAA when given to patients with KD within 10 days of fever onset. Children with KD may undergo evaluation for other diagnoses before treatment, particularly those with incomplete KD criteria.
View Article and Find Full Text PDFBackground: The real-world application of STRIDE-II treatment targets to identify whether disease control is optimal in Crohn's disease (CD) and ulcerative colitis (UC) is not well known.
Aims: This study aimed to estimate proportions of patients with suboptimally controlled CD and UC in real-world Canadian healthcare settings and the impact on quality of life (QoL).
Methods: The noninterventional, multicenter, observational IBD-PODCAST Canada study comprised a single study visit involving routine assessments, patient- and clinician-completed questionnaires, and a retrospective chart review.